UrgentRx Secures $17,500,000 Series C Funding

  • Feed Type
  • Date
    6/30/2014
  • Company Name
    UrgentRx
  • Mailing Address
    1610 Wynkoop St. Denver, CO 80202 USA
  • Company Description
    UrgentRx is a line of fast-acting, portable OTC medications providing right now relief for today’s busy, on-the-go consumer. UrgentRx Fast Powders come in an innovative, fast-acting flavored powder format available in convenient, single-dose, credit-card-sized packets for easier portability and accessibility.
  • Website
    http://www.urgentrx.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $17,500,000
  • Transaction Round
    Series C
  • Proceeds Purposes
    The company will use the proceeds for sales and marketing expansion initiatives.
  • M&A Terms
  • Venture Investor
  • Venture Investor
  • Venture Investor

Trending on Xconomy